Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.7%

2 terminated out of 43 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (26)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Completed18
Unknown11
Recruiting7
Not Yet Recruiting4
Terminated2
Withdrawn1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT07386093Not ApplicableNot Yet RecruitingPrimary

The Effect of Skin Color Scale Material Used by Families at Home in the Postnatal Period on the Process of Hospital Admission Due to Jaundice and Breastfeeding Parameters

NCT07315126Not Yet RecruitingPrimary

Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns

NCT04365998Not ApplicableRecruitingPrimary

BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice

NCT06963450RecruitingPrimary

NeoSCB App for Screening Jaundice in Newborns

NCT07077941Not ApplicableNot Yet Recruiting

Comparing Integrative Midwife-led vs. Fragmented Inpatient Postpartum Care: Impact on Satisfaction and Transition to Motherhood

NCT06595368Not ApplicableCompletedPrimary

Comparing the Effect of Vimala Massage Versus Hydrotherapy on the Clinical Outcomes of Neonatal Hyperbilirubinemia

NCT06653374Completed

Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns

NCT06650293Not ApplicableCompletedPrimary

Effect of Vitamin D Supplementation as Adjuvant Therapy in Neonatal Jaundice in Combination With Phototherapy

NCT06628726Not ApplicableNot Yet Recruiting

Liver Biopsy in Diagnosis Neonatal Jaundice

NCT05521607Not ApplicableRecruitingPrimary

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

NCT06073444Not ApplicableCompletedPrimary

mHealth to Screen for Neonatal Jaundice in Low-resource Mexican Settings: a Feasibility Study

NCT06451900Phase 4CompletedPrimary

Role of Fenofibrate in Neonatal Jaundice

NCT06087874Phase 2RecruitingPrimary

Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice

NCT06399146Not ApplicableRecruitingPrimary

Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana

NCT06386731Not ApplicableCompletedPrimary

Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice

NCT05365399Not ApplicableTerminatedPrimary

Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population

NCT06341582RecruitingPrimary

Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia Cohort

NCT06329843RecruitingPrimary

Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro

NCT06227624Phase 3CompletedPrimary

Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia

NCT06075290UnknownPrimary

the Difference of Follow-up Methods of Neonatal Jaundice

Scroll to load more

Research Network

Activity Timeline